NeoGenomics, Inc. (NASDAQ: NEO) commenced an underwritten public offering of approximately $150,000,000 of newly issued shares of common stock. All ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE